| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 7, 2026 | ±1.6% | -1.3% | over-priced |
| November 5, 2025 | ±2.2% | +0.3% | over-priced |
| August 6, 2025 | ±2.4% | +1.2% | over-priced |
| May 7, 2025 | ±4.6% | +0.5% | over-priced |
| November 6, 2024 | ±2.0% | +6.3% | under-priced |
| August 7, 2024 | ±3.3% | -0.2% | over-priced |
| May 8, 2024 | ±5.0% | +5.1% | under-priced |
| November 6, 2023 | ±1.9% | -0.9% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $3.39 | $1.6B | $271M |
| Q4 FY2025 | $3.30 | $1.5B | $266M |
| Q3 FY2025 | $4.73 | $1.5B | $388M |
| Q2 FY2025 | $3.05 | $1.5B | $253M |
Globe Life Inc. (GL) reports in 99 days, with the next report estimated for September 20, 2026. Across the last 8 reports, options priced an average ±2.9% earnings move while the stock actually moved 2.0% on average — the market has systematically over-priced GL's earnings risk. Fundamentals into the print: EPS up 12.6% year-over-year, revenue up 5.3%. QuantLogix's live 5-factor engine currently reads GL as a buy at 66/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →